Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 174 participants.

Also called NCT01382303

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 174 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01382303
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01382303. Randomized; double masking; primary purpose treatment. Start 2010-10-25 (actual); primary completion 2013-12-20 (actual). Results posted on 2017-06-16.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic Patients
Intervention (Drug)
Pentoxifylline
Intervention (Drug)
Placebo
Lead sponsor
Ajou University School of Medicine (class: other)
Collaborator
Bundang CHA Hospital (class: other)
Collaborator
Hallym University Medical Center (class: other)
Collaborator
Gangnam Severance Hospital (class: other)
Collaborator
Yonsei University (class: other)
Collaborator
Myongji Hospital (class: other)

Record details

Record id
cardio:ct-nct01382303
Content hash
8c0981387f113530e09c595476973650c58f2a2110c6563e36150e3c0600311d